Results 71 to 80 of about 20,495 (161)

Use of Glucagon-Like Peptide-1 Receptor Agonists and Risk of Parkinson's Disease: Scandinavian Cohort Study. [PDF]

open access: yesDiabetes Obes Metab
Engström A   +10 more
europepmc   +1 more source

Lead optimization of AMS-17 identifies AMS-4 as a modulator of inflammasome-driven cocaine-associated neuroinflammation. [PDF]

open access: yesBiochem Biophys Res Commun
Singh S   +7 more
europepmc   +1 more source

Kidney outcomes with GLP-1 receptor agonists in people with type 2 diabetes already receiving SGLT2 inhibitors: a target trial emulation study using UK primary care data.

open access: yesLancet Prim Care
Jansz TT   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy